Literature DB >> 9891849

Characterization of mouse ubiquitin-like SMT3A and SMT3B cDNAs and gene/pseudogenes.

A Chen1, H Mannen, S S Li.   

Abstract

Mouse SMT3A and SMT3B cDNAs encoding ubiquitin-like proteins of 110 and 95 amino acids, respectively, were isolated and sequenced. The sequence of the first 92 amino acids (ending with the conserved Gly-Gly) of mouse SMT3A exhibited two differences at amino acid no. 38 and 76 in comparison with that of human SMT3A. The C-terminal 18 amino acid sequence of mouse SMT3A was completely different from the C-terminal 11 amino acid sequence of human SMT3A. Mouse and human SMT3B were identical for a sequence of 95 amino acids. Mouse SMT3A genomic DNAs were amplified by polymerase-chain-reaction and sequenced. The nucleotide sequence of a PCR-amplified SMT3A genomic DNA fragment was found to be identical to that of SMT3A cDNA, indicating the absence of intron(s) in its protein coding region. Another genomic DNA fragment of 1,531 nucleotides, containing 7% differences from that of cDNA, is unable to encode a functional protein, and thus, it is a SMT3A processed pseudogene. Three mouse SMT3B processed pseudogenes were cloned and sequenced. The genuine mouse SMT3B gene has not yet been isolated. Mouse SMT3A transcript of 1.8 kb was predominantly expressed in most tissues, while SMT3B transcript of 1.0 kb was abundantly present in all tissues analyzed. A family of ubiquitin-like proteins was recently discovered. One distinguishing feature of ubiquitin and ubiquitin-like proteins is the capacity to conjugate with other proteins post-translationally. The ubiquitin-like proteins are cleaved endoproteolytically after a diglycine sequence, corresponding to the C-terminal Gly75-Gly76 of ubiquitin. The cleavage activates the molecule for conjugation. The yeast SMT3 gene was originally identified as a suppressor of mutations in MIF2 gene, which encodes an essential protein binding to the A+T-rich CDEII region of centromere DNA (1). Studies using temperature-sensitive mutants showed that the loss of yeast Mif2 protein function results in chromosome missegregation, mitotic delay, and aberrant microtubule morphologies (2). The yeast Mif2 protein shares at least two regions of similarity with mammalian centromere protein CENP-C, an integral component of active kinetochores (3, 4). Human SMT3A cDNA was identified from the genome sequencing project of chromosome 21 (5). We have cloned human SMT3B (formerly designated as HSMT3) cDNA (6). Human SMT3C protein was independently isolated by several groups and denoted as SUMO-1 (7), GMP1 (8), PICI (9), UBL1 (10), sentrin (11). SUMO-1/GMP1 was found to be covalently linked to the Ran GTPase-activating protein RanGAP1, and attachment of SUMO-1 targets the otherwise cytosolic RanGAP1 to the nuclear pore complex. The modified form of RanGAP1 also appeared to associate with the mitotic spindle apparatus during mitosis (7, 8). PIC1 was shown to interact with the PML component of nuclear multiprotein complex that is disrupted in acute promyelocytic leukemia (9). UBL1 was found to associate with human RAD51/RAD52 proteins involved in DNA recombination and DNA double-strand break repair (10). Sentrin was shown to interact with Fas/APO-1 or the TNF receptor 1 death domain, and the overexpression of sentrin provided protection against both anti-Fas/APO-1 and TNF-induced cell death (11). Here we report the characterization of mouse SMT3A and SMT3B cDNAs, gene/pseudogenes, and mRNA expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9891849     DOI: 10.1080/15216549800204722

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  14 in total

Review 1.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

2.  Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.

Authors:  Xavier H Mascle; Mathieu Lussier-Price; Laurent Cappadocia; Patricia Estephan; Luca Raiola; James G Omichinski; Muriel Aubry
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

Review 3.  SUMO and SUMOylation in plants.

Authors:  Hee Jin Park; Woe-Yeon Kim; Hyeong Cheol Park; Sang Yeol Lee; Hans J Bohnert; Dae-Jin Yun
Journal:  Mol Cells       Date:  2011-09-09       Impact factor: 5.034

4.  RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2alpha.

Authors:  Martijn van Hagen; René M Overmeer; Sharareh S Abolvardi; Alfred C O Vertegaal
Journal:  Nucleic Acids Res       Date:  2009-12-21       Impact factor: 16.971

Review 5.  SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases.

Authors:  Wei Yang; Wulf Paschen
Journal:  Proteomics       Date:  2014-10-28       Impact factor: 3.984

6.  Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation.

Authors:  K Tanaka; J Nishide; K Okazaki; H Kato; O Niwa; T Nakagawa; H Matsuda; M Kawamukai; Y Murakami
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

7.  Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts.

Authors:  Jun Wang; AnKang Li; ZhiGao Wang; XinHua Feng; Eric N Olson; Robert J Schwartz
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

8.  Sumoylation dynamics during keratinocyte differentiation.

Authors:  Adeline F Deyrieux; Germán Rosas-Acosta; Michelle A Ozbun; Van G Wilson
Journal:  J Cell Sci       Date:  2006-12-12       Impact factor: 5.285

Review 9.  SUMOylation targeting mitophagy in cardiovascular diseases.

Authors:  Hong Xiao; Hong Zhou; Gaofeng Zeng; Zhenjiang Mao; Junfa Zeng; Anbo Gao
Journal:  J Mol Med (Berl)       Date:  2022-09-26       Impact factor: 5.606

10.  The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing.

Authors:  Lin Nan Shen; Changjiang Dong; Huanting Liu; James H Naismith; Ronald T Hay
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.